DermWireTV: Incyte's Opzelura, BMS Patient Week, Science of Skincare Summit - Practical Dermatology - 亚博APP手机登录网页版,亚博yabo网页登录

Topics:

Acne

Cosmetic

2020年亚博收网行动

Infections

Pediatric

亚博网站有诚信的

Psoriasis

Residents

2020年亚博论坛

皮肤Cancer

皮肤of Color

DermWireTV: Incyte's Opzelura, BMS Patient Week, Science of Skincare Summit

September 30, 2021

Incyte的Opzelura是第一个局部木菠萝抑制or approved in the US. Lawrence Eichenfield, MD weighs in on the cream formulation of ruxolitinib for treatment of mild-to-moderate atopic dermatitis in non-immunocompromised patients 12 years of age and older. Bristol Myers Squibb's seventh Global Patient Week brings attention on the needs of patients, including those with psoriasis. The Science of Skincare Summit is coming November 6 to New York City. The program, founded by Dermatologists Dr. Patti Farris and Dr. Ted Lain, offers both virtual and live attendance.

In This Series

DermWireTV: SPF Accuracy, Dupixent PN Data, AD Pipeline thumbnail

DermWireTV: SPF Accuracy, Dupixent PN Data, AD Pipeline

DermWireTV: Sun Hero Launch; Eczema Awareness Month; ASDSA Hails Hyaluron Pen Warning thumbnail

DermWireTV: Sun Hero Launch; Eczema Awareness Month; ASDSA Hails Hyaluron Pen Warning

DermWireTV: Incyte's Opzelura, BMS Patient Week, Science of Skincare Summit thumbnail

DermWireTV: Incyte's Opzelura, BMS Patient Week, Science of Skincare Summit

DermWireTV: NPF on Boosters; Galderma Raises Awareness, World Eczema Day, and more thumbnail

DermWireTV: NPF on Boosters; Galderma Raises Awareness, World Eczema Day, and more

View More

Featured Dermtube Video Series